ABOS — Acumen Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall CapMomentum Trap
- $241.31m
- $96.43m
- 34
- 33
- 64
- 39
Annual balance sheet for Acumen Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 6.55 | 43.8 | 194 | 178 |
| Net Total Receivables | 0.03 | 0.109 | 0 | — |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 7.18 | 44.4 | 199 | 180 |
| Net Property, Plant And Equipment | — | — | 0.036 | 0.27 |
| Long Term Investments | ||||
| Other Long Term Assets | ||||
| Total Assets | 7.32 | 44.4 | 230 | 197 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 1.34 | 6.37 | 5.15 | 7.81 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 1.34 | 6.37 | 5.15 | 7.81 |
| Redeemable Preferred Stock | ||||
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 5.98 | 38.1 | 225 | 189 |
| Total Liabilities & Shareholders' Equity | 7.32 | 44.4 | 230 | 197 |
| Total Common Shares Outstanding |